Bid Banana
PricingBid helpAPILog inStart free trial
Log inStart free trial

Learn more

  • Federal contracts (SAM.gov)The Ultimate Guide to SAM.gov Registration
  • Healthcare RFPsHealthcare and Medical Services Bids and Bidding Guide
  • How to answer an RFIRFI Meaning: What Is an RFI?
More healthcare and medical services bids →Must-win bid? Bring in The Bid Lab →
Bid Banana
SearchPricingBid helpBrowse bidsAPISupportFAQPrivacy PolicyTerms of UseAI Use Policy

This website and its content is copyright of The Bid Lab © 2026. The Bid Lab is a trademark of Bid Lab, LLC. All rights reserved.

  1. Bid Banana
  2. ›Closed bids
  3. ›Federal
  4. ›AJ11--Pharmacokinetic Studies

U.S. Department Of Veterans Affairs·Florida

AJ11--Pharmacokinetic Studies

Closes 8/17/2026$100k – $500kRequest for Information
Bid source

This opportunity has closed.

Bid Banana tracks 1.6M+ bids and awards across all 50 states. Save a search and we'll email your new matches, daily or weekly — so the next one reaches you with time to bid.

Get alerted next time

Description

The Department of Veterans Affairs is seeking information for pharmacokinetic studies of NPC86. The contractor will be required to develop an HPLC-MS/MS method for the quantification of NPC86 in mouse plasma and optimize an LC-MS/MS RGA2 method for the quantification of NPC86 in mouse tissues. The contractor will also be required to conduct a pharmacokinetic and biodistribution study of NPC86 by intranasal administration or intraperitoneal injection in the C57BL/6 mouse. The qualifications of the contractor's personnel shall require expertise uniquely suited to bioanalytical sciences and animal research. Some key points to consider include: • Development of an HPLC-MS/MS method for the quantification of NPC86 in mouse plasma • Optimization and qualification of an LC-MS/MS RGA2 method for the quantification of NPC86 in mouse tissues • Conducting a pharmacokinetic and biodistribution study of NPC86 by intranasal administration or intraperitoneal injection in the C57BL/6 mouse • Ensuring animal welfare compliance through approved procedures, veterinary oversight, and appropriate housing and monitoring • Providing written assurance to the competency of personnel and a list of credentials of approved field service engineers

Attached files

Contact

Keila President(Contract Specialist)

[email protected]

Key dates

Opened
8/12/2026
Closes
8/17/2026

Last updated

Details

Type
Request for Information
Industry
Healthcare and Medical Services
NAICS
541715
Solicitation №
36C24826Q0962

Budget estimate

$100,000 – $500,000

The budget for this opportunity is difficult to estimate because the document does not provide a specific budget or pricing information. However, based on the scope of work, which includes method development, optimization, and qualification, as well as a pharmacokinetic and biodistribution study, the budget could be in the range of $100,000 to $500,000. This estimate is based on the assumption that the contractor will need to invest significant resources in personnel, equipment, and facilities to complete the required tasks. Factors that may influence the likely payment range include the complexity of the methods to be developed, the number of samples to be analyzed, and the level of expertise required for the personnel involved.

AI estimate from the solicitation

Similar opportunities

Matched by Bid Banana AI™

Bid Banana · 1.6M+ bids and awards 🍌

You found this one too late. Don't find the next one too late.

Bid Banana searches open government bids across all 50 states, updated daily. Save a search once and we email you your new matches, daily or weekly, while there is still time to win them.

1.6M+
bids & awards
All 50
states
4,000+
agencies
Start your 7-day free trial

Plans from $49.99/month. Cancel anytime, no setup fees.

Built by The Bid Lab, answering RFPs since 2017.

U.S. Food and Drug Administration·United States of America

Top match · 71%

Evaluating the Cutaneous Pharmacokinetics of Topical Drug Products Using Pharmacokinetic Tomography (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

67% match

Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/21/2023

U.S. Food and Drug Administration·United States of America

67% match

Identification of Drug-related and Formulation-Related Factors that Result in Alcohol Dose Dumping of Modified Release Oral Drug Products (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

66% match

Applied regulatory science research to evaluate and treat cardiotoxicity of oncology therapeutics

Rolling / TBD closeOpened 11/20/2024

U.S. Food and Drug Administration·United States of America

65% match

Synthesis and Biological Activity Assessment of Different Diastereomers in siRNA Drug LEQVIO (Inclisiran) (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. National Institutes of Health·United States of America

65% match

Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)

Closes 11/5/2027Opened 11/15/2021

U.S. Department Of Health And Human Services·United States of America

64% match

Pre-Clinical Models of Infectious Diseases

Closes 12/7/2026Opened 10/19/2026

U.S. National Institutes of Health·United States of America

63% match

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Closes 9/10/2027Opened 12/13/2024

U.S. Department Of Health And Human Services·United States of America

63% match

Synthesis and Distribution of Drugs of Abuse and Related Compounds

Closes 11/20/2026Opened 10/29/2026

U.S. Food and Drug Administration·United States of America

63% match

Identification and Evaluation of Possible Approaches to Addressing Nitrosamine Impurities in Drugs (U01)

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

62% match

Cooperative Agreement to Support a Human Abuse Potential Study of Botanical Kratom (U01 Clinical Trial Required)

Rolling / TBD closeOpened 11/24/2023

U.S. Food and Drug Administration·United States of America

62% match

Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional

Rolling / TBD closeOpened 11/24/2023

U.S. Department Of Health And Human Services·Maryland

62% match

Stability Testing for ManNAc Drug Product produced in Campaigns 5 and 6. Stability testing will occur under regulatory compliance

Closes 11/9/2026Opened 10/28/2026

U.S. National Institutes of Health·United States of America

62% match

Improved Drug Susceptibility Testing (DST) for Mycobacteria

Closes 5/27/2027Opened 6/24/2026

U.S. Food and Drug Administration·United States of America

62% match

Minor Use Minor Species Development of Drugs (R01)

Rolling / TBD closeOpened 11/30/2023

U.S. Department Of Veterans Affairs·Missouri

62% match

AJ12--Development/Production - Kidney GEC-Specific AAV Vector

Closes 11/4/2026Opened 10/21/2026

U.S. National Institutes of Health·United States of America

61% match

Mechanistic Toxicology of METALS: Metal Exposure, Transport, Action, Localization, and Susceptibility (RP1 Clinical Trial Not Allowed)

Closes 1/4/2027Opened 9/14/2026

City of Tulsa·Oklahoma

61% match

Drug Testing Lab Services

Closes 11/4/2026Opened 10/10/2026

U.S. Food and Drug Administration·United States of America

61% match

Minor Use Minor Species Development of Drugs (R01)

Closes 1/29/2027Opened 5/29/2024

U.S. Food and Drug Administration·United States of America

61% match

Cooperative Agreement to Support Activities Related to Analgesics, Anesthetics, and Addiction (U01) Clinical Trials Allowed

Rolling / TBD closeOpened 8/14/2024

U.S. National Institutes of Health·United States of America

61% match

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development

Closes 6/15/2027Opened 7/7/2026

U.S. Department Of Transportation·United States of America

61% match

Experimental and Mathematical Biomechanics Injury Research IDIQ

Closes 11/30/2026Opened 10/15/2026

U.S. National Institutes of Health·United States of America

61% match

Advancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)

Closes 3/5/2029Opened 7/22/2025

U.S. Food and Drug Administration·United States of America

61% match

Utilizing Real-World Data and Algorithmic Analyses to Assess Post-Market Clinical Outcomes in Patients Switching Amongst Therapeutically Equivalent Complex Generic Drug Products and Reference Listed Drugs (U01) Clinical Trial Not Allowed

Rolling / TBD closeOpened 11/24/2023

U.S. Defense Health Agency Contracting Activity - DHACA·United States of America

61% match

DoW Toxic Exposures Investigator Initiated Research Award

Closes 11/19/2026Opened 5/7/2026